No insider purchase over the last 90 days. The latest, by 이동현, was filed 06 May 2026.
HLscience Co., Ltd.: what insiders have been doing
HLscience Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through DART (FSS). Over the twelve months to 31 October 2026, 9 filings were filed, from 4 insiders.
Only purchases show up on the open market, 7 purchases in all worth €240k, filed by 2 insiders. The totals exclude 3 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €102k, bought by 이동현 and made public on 6 March 2026 (0.64% of market cap). Among those who bought: 1 senior executive.
The last insider purchase was made public on 6 May 2026, 188 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 5 days. That lag is the time during which only the insider knows about the trade.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 9 filings here. Over the whole record (from 2021), the tally stands at 9 purchases and 3 sales.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -28.4%Entry ₩8,310 · Close 30 Oct 2026 ₩5,950
- -21.8%Entry ₩7,610 · Close 30 Oct 2026 ₩5,950
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 10,684 shares@ ₩8,565.34750.32% mcap40.0% of flowShareKRXDART:20260506000637Canonical exit: 27 Jul 2026 (T+90)
- 17,441 shares@ ₩7,910.41150.48% mcap60.0% of flowShareKRXDART:20260417000695Canonical exit: 13 Jul 2026 (T+90)
- ShareKRXDART:20260312001017
- 1,134 shares@ ₩8,084.000.033% mcap4.9% of flowShareKRXDART:20260311004116Canonical exit: 7 Jun 2026 (T+90)
- 54,147 sharesKRXDART:20260311004171Canonical exit: 3 Jun 2026 (T+90)
- ●Executives0DART
- 20,796 shares@ ₩8,293.6630.64% mcap95.1% of flowShareKRXDART:20260306000903Canonical exit: 27 May 2026 (T+90)
- 13,846 sharesShareKRXDART:20260226005833Canonical exit: 27 May 2026 (T+90)
- 17,566 sharesShareKRXDART:20260219002413Canonical exit: 20 May 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- ShareKRXDART:20240906000643
- ShareKRXDART:20230907000320
- ●Executives0DART
- ●Executives0DART
- 2,187 sharesShareKRXDART:20220406002308
- 2,187 sharesKRXDART:20220406002264
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ShareKRXDART:20211019000260
- 855 sharesKRXDART:20210528000899Canonical exit: 26 Aug 2021 (T+90)
- ShareKRXDART:20210528000960
- ShareKRXDART:20210329000723
25 of 31 declarations
About HLscience Co., Ltd.
Listed on the XKRX market, 에이치엘사이언스 is a company in the healthcare and pharmaceutical sector. It focuses on developing innovative solutions to enhance healthcare.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
